{"id":20344,"date":"2021-03-30T00:00:00","date_gmt":"2021-03-30T00:00:00","guid":{"rendered":"https:\/\/fundacionnoelia.org\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/"},"modified":"2022-05-09T10:37:38","modified_gmt":"2022-05-09T10:37:38","slug":"an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil","status":"publish","type":"post","link":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/","title":{"rendered":"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil"},"content":{"rendered":"\r\n<p>In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the harmful effects that a dysfunctional collagen matrix causes on muscle cells, slowly promoting their destruction. This is the case of alisporivir or givinostat which, like omigapil, have been frequently mentioned in publications and have been the object of both preclinical studies and clinical trials. In this article we summarize what is known about these products, their potential applicability in patients with collagen-VI muscular dystrophy and the current state of their clinical development.<\/p>\r\n\r\n\r\n\r\n<p><a href=\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/TERAPIAS-COADYUVANTES_ENG.pdf\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"URL\" data-id=\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/TERAPIAS-COADYUVANTES_ENG.pdf\">See here full article<\/a><\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the harmful effects that a dysfunctional collagen matrix causes on muscle cells, slowly promoting their destruction.&hellip;<\/p>\n","protected":false},"author":1,"featured_media":16030,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[112,113],"tags":[],"post_series":[],"class_list":["post-20344","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-collagenvi-articles-2","category-day-to-day-fundation","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil - Fundaci\u00f3n Noelia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil - Fundaci\u00f3n Noelia\" \/>\n<meta property=\"og:description\" content=\"In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the harmful effects that a dysfunctional collagen matrix causes on muscle cells, slowly promoting their destruction.&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\" \/>\n<meta property=\"og:site_name\" content=\"Fundaci\u00f3n Noelia\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-30T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-09T10:37:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"920\" \/>\n\t<meta property=\"og:image:height\" content=\"920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#\/schema\/person\/251bd215dfe4e3e40da6badb9ce8adc8\"},\"headline\":\"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil\",\"datePublished\":\"2021-03-30T00:00:00+00:00\",\"dateModified\":\"2022-05-09T10:37:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\"},\"wordCount\":130,\"publisher\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg\",\"articleSection\":[\"CollagenVI \u2013 Articles\",\"Day-to-day\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\",\"url\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\",\"name\":\"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil - Fundaci\u00f3n Noelia\",\"isPartOf\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg\",\"datePublished\":\"2021-03-30T00:00:00+00:00\",\"dateModified\":\"2022-05-09T10:37:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage\",\"url\":\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg\",\"contentUrl\":\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg\",\"width\":920,\"height\":920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/fundacionnoelia.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"90\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#website\",\"url\":\"https:\/\/fundacionnoelia.org\/en\/\",\"name\":\"Fundaci\u00f3n Noelia\",\"description\":\"Just another WordPress site\",\"publisher\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fundacionnoelia.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#organization\",\"name\":\"Fundaci\u00f3n Noelia\",\"url\":\"https:\/\/fundacionnoelia.org\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2022\/04\/logo_fundacion_noelia_transparente_peq.png\",\"contentUrl\":\"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2022\/04\/logo_fundacion_noelia_transparente_peq.png\",\"width\":391,\"height\":150,\"caption\":\"Fundaci\u00f3n Noelia\"},\"image\":{\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/fundacionnoelia.org\/en\/#\/schema\/person\/251bd215dfe4e3e40da6badb9ce8adc8\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/98051a330a82b2814b4485351c5b498dc07ddb78b7af1b7b43a10c08205f6f46?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/98051a330a82b2814b4485351c5b498dc07ddb78b7af1b7b43a10c08205f6f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/98051a330a82b2814b4485351c5b498dc07ddb78b7af1b7b43a10c08205f6f46?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/fundacionnoelia.org\"],\"url\":\"https:\/\/fundacionnoelia.org\/en\/actualidad\/author\/admin_h6lwguow\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil - Fundaci\u00f3n Noelia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/","og_locale":"en_US","og_type":"article","og_title":"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil - Fundaci\u00f3n Noelia","og_description":"In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the harmful effects that a dysfunctional collagen matrix causes on muscle cells, slowly promoting their destruction.&hellip;","og_url":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/","og_site_name":"Fundaci\u00f3n Noelia","article_published_time":"2021-03-30T00:00:00+00:00","article_modified_time":"2022-05-09T10:37:38+00:00","og_image":[{"width":920,"height":920,"url":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#article","isPartOf":{"@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/"},"author":{"name":"admin","@id":"https:\/\/fundacionnoelia.org\/en\/#\/schema\/person\/251bd215dfe4e3e40da6badb9ce8adc8"},"headline":"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil","datePublished":"2021-03-30T00:00:00+00:00","dateModified":"2022-05-09T10:37:38+00:00","mainEntityOfPage":{"@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/"},"wordCount":130,"publisher":{"@id":"https:\/\/fundacionnoelia.org\/en\/#organization"},"image":{"@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage"},"thumbnailUrl":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg","articleSection":["CollagenVI \u2013 Articles","Day-to-day"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/","url":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/","name":"An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil - Fundaci\u00f3n Noelia","isPartOf":{"@id":"https:\/\/fundacionnoelia.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage"},"image":{"@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage"},"thumbnailUrl":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg","datePublished":"2021-03-30T00:00:00+00:00","dateModified":"2022-05-09T10:37:38+00:00","breadcrumb":{"@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#primaryimage","url":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg","contentUrl":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2021\/05\/MEDICINE.jpg","width":920,"height":920},{"@type":"BreadcrumbList","@id":"https:\/\/fundacionnoelia.org\/en\/actualidad\/an-update-on-potential-adjuvant-therapies-in-collagen-vi-cmd-alisporivir-givinostat-and-omigapil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fundacionnoelia.org\/en\/"},{"@type":"ListItem","position":2,"name":"90"}]},{"@type":"WebSite","@id":"https:\/\/fundacionnoelia.org\/en\/#website","url":"https:\/\/fundacionnoelia.org\/en\/","name":"Fundaci\u00f3n Noelia","description":"Just another WordPress site","publisher":{"@id":"https:\/\/fundacionnoelia.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fundacionnoelia.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fundacionnoelia.org\/en\/#organization","name":"Fundaci\u00f3n Noelia","url":"https:\/\/fundacionnoelia.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fundacionnoelia.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2022\/04\/logo_fundacion_noelia_transparente_peq.png","contentUrl":"https:\/\/fundacionnoelia.org\/wp-content\/uploads\/2022\/04\/logo_fundacion_noelia_transparente_peq.png","width":391,"height":150,"caption":"Fundaci\u00f3n Noelia"},"image":{"@id":"https:\/\/fundacionnoelia.org\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fundacionnoelia.org\/en\/#\/schema\/person\/251bd215dfe4e3e40da6badb9ce8adc8","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/98051a330a82b2814b4485351c5b498dc07ddb78b7af1b7b43a10c08205f6f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/98051a330a82b2814b4485351c5b498dc07ddb78b7af1b7b43a10c08205f6f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/98051a330a82b2814b4485351c5b498dc07ddb78b7af1b7b43a10c08205f6f46?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/fundacionnoelia.org"],"url":"https:\/\/fundacionnoelia.org\/en\/actualidad\/author\/admin_h6lwguow\/"}]}},"_links":{"self":[{"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/posts\/20344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/comments?post=20344"}],"version-history":[{"count":1,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/posts\/20344\/revisions"}],"predecessor-version":[{"id":20708,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/posts\/20344\/revisions\/20708"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/media\/16030"}],"wp:attachment":[{"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/media?parent=20344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/categories?post=20344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/tags?post=20344"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/fundacionnoelia.org\/en\/wp-json\/wp\/v2\/post_series?post=20344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}